Next Article in Journal
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
Previous Article in Journal
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
 
 
Article

Article Versions Notes

Cancers 2024, 16(1), 155; https://doi.org/10.3390/cancers16010155
Action Date Notes Link
article xml file uploaded 28 December 2023 11:57 CET Original file -
article xml uploaded. 28 December 2023 11:57 CET Update -
article pdf uploaded. 28 December 2023 11:57 CET Version of Record -
article supplementary file uploaded. 28 December 2023 11:57 CET - https://www.mdpi.com/2072-6694/16/1/155#supplementary
article html file updated 28 December 2023 11:59 CET Original file -
article html file updated 28 December 2023 12:07 CET Update -
article xml file uploaded 28 December 2023 12:11 CET Update -
article xml uploaded. 28 December 2023 12:11 CET Update -
article pdf uploaded. 28 December 2023 12:11 CET Updated version of record -
article xml file uploaded 28 December 2023 12:12 CET Update -
article xml uploaded. 28 December 2023 12:12 CET Update -
article pdf uploaded. 28 December 2023 12:12 CET Updated version of record -
article html file updated 28 December 2023 12:13 CET Update -
article xml file uploaded 28 December 2023 12:14 CET Update -
article xml uploaded. 28 December 2023 12:14 CET Update -
article pdf uploaded. 28 December 2023 12:14 CET Updated version of record -
article html file updated 28 December 2023 12:14 CET Update -
article html file updated 28 December 2023 12:15 CET Update -
article xml file uploaded 28 December 2023 12:21 CET Update -
article xml uploaded. 28 December 2023 12:21 CET Update https://www.mdpi.com/2072-6694/16/1/155/xml
article pdf uploaded. 28 December 2023 12:21 CET Updated version of record https://www.mdpi.com/2072-6694/16/1/155/pdf
article html file updated 28 December 2023 12:23 CET Update https://www.mdpi.com/2072-6694/16/1/155/html
article supplementary file uploaded. 29 December 2023 08:08 CET - https://www.mdpi.com/2072-6694/16/1/155#supplementary
Back to TopTop